Julia Sousa Lins

Julia Sousa Lins

Auto-generated profile, based on publicly available information

Julia Sousa Lins

Hospital Sirio Libanês, Oncologia Clínica

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2024 in Brazilian Journal of Oncology
Verified
Journal Article
Open access
NLNildevande Firmino Lima
Nildevande Firmino Lima
MQMarcello Moro Queiroz
Marcello Moro Queiroz
JFJulia Sousa Leal Franco
Julia Sousa Leal Franco
JLJulia Sousa Lins
Julia Sousa Lins
ECEduardo Felício de Campos
Eduardo Felício de Campos
RMRodrigo Ramella Munhoz
Rodrigo Ramella Munhoz
Recognition of the molecular basis of gastrointestinal stromal tumors has paved the way for significant breakthroughs in the diagnosis and treatment of this disease as well as positioned gastrointestinal stromal tumors as a framework for the concept of precision oncology in solid tumors. The incorporation of novel targeted agents for molecularly defined subgroups has led to significant improvements in treatment outcomes; however, the characterization of heterogeneous KIT or PDGFRA mutations and the emergence of resistance mechanisms highlight the need for a broader use of comprehensive molecular profiling and emphasize the importance of molecularly driven adaptive treatment strategies. Such a molecular background is critical for developing personalized and effective interventions and optimizing outcomes. The present review summarizes key studies that provide the basis for standard-of-care management options as well as provides molecular insights into the management of gastrointestinal stromal tumors, with an emphasis on recent advances.